Literature DB >> 20716758

New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems.

Alexandre Abizaid1, J Ribamar Costa.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20716758     DOI: 10.1161/CIRCINTERVENTIONS.109.891192

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


× No keyword cloud information.
  26 in total

1.  Electrochemical etching of micro-pores in medical grade cobalt-chromium alloy as reservoirs for drug eluting stents.

Authors:  Kai Fuchsberger; Karoline Binder; Claus Burkhardt; Christian Freudigmann; Markus Herrmann; Martin Stelzle
Journal:  J Mater Sci Mater Med       Date:  2016-01-12       Impact factor: 3.896

2.  A clinical evaluation of the ProNOVA XR polymer-free sirolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions (EURONOVA XR I study).

Authors:  Jacek Legutko; Wojciech Zasada; Grzegorz L Kałuża; Grzegorz Heba; Lukasz Rzeszutko; Jacek Jakala; Jacek Dragan; Artur Klecha; Dawid Giszterowicz; Wojciech Dobrowolski; Lukasz Partyka; Swaminathan Jayaraman; Dariusz Dudek
Journal:  Indian Heart J       Date:  2013-07-21

Review 3.  Enhancing Stent Effectiveness with Nanofeatures.

Authors:  Nicole Bassous; John P Cooke; Thomas J Webster
Journal:  Methodist Debakey Cardiovasc J       Date:  2016-09

4.  Combinatorial therapy of sirolimus and heparin by nanocarrier inhibits restenosis after balloon angioplasty ex vivo.

Authors:  Jayesh Betala; Sooneon Bae; Eugene M Langan; Martine LaBerge; Jeoung Soo Lee
Journal:  Nanomedicine (Lond)       Date:  2020-04-28       Impact factor: 5.307

Review 5.  Drug-eluting stents versus bare-metal stents for acute coronary syndrome.

Authors:  Joshua Feinberg; Emil Eik Nielsen; Janette Greenhalgh; Juliet Hounsome; Naqash J Sethi; Sanam Safi; Christian Gluud; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2017-08-23

Review 6.  Thrombotic responses to coronary stents, bioresorbable scaffolds and the Kounis hypersensitivity-associated acute thrombotic syndrome.

Authors:  Nicholas G Kounis; Ioanna Koniari; Anastasios Roumeliotis; Grigorios Tsigkas; George Soufras; Nicholas Grapsas; Periklis Davlouros; George Hahalis
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

7.  OPTIMA Tacrolimus-eluting Stent: A Twelve-month Clinical Follow up with Two Different Periods of Dual Antiplatelet Therapy; 2-month vs. 6-month Approach.

Authors:  Nasser Aslanabadi; Ahmad Separham; Reza Beheshti; Samad Ghaffari; Bahram Sohrabi
Journal:  J Cardiovasc Thorac Res       Date:  2012-09-23

Review 8.  Translational research on novel drug-eluting stents in percutaneous coronary intervention.

Authors:  Yaling Han; Kai Xu; Chenghui Yan
Journal:  Front Med       Date:  2011-12-27       Impact factor: 4.592

9.  Synthesis, characterization, and paclitaxel release from a biodegradable, elastomeric, poly(ester urethane)urea bearing phosphorylcholine groups for reduced thrombogenicity.

Authors:  Yi Hong; Sang-Ho Ye; Anca L Pelinescu; William R Wagner
Journal:  Biomacromolecules       Date:  2012-10-18       Impact factor: 6.988

10.  Biodegradable-Polymer Biolimus-Eluting Stents versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study.

Authors:  Ehsan Parsa; Sepideh Saroukhani; Fereshteh Majlessi; Hamidreza Poorhosseini; Masoumeh Lofti-Tokaldany; Arash Jalali; Mojtaba Salarifar; Ebrahim Nematipour; Mohammad Alidoosti; Hassan Aghajani; Alireza Amirzadegan; Seyed Ebrahim Kassaian
Journal:  Tex Heart Inst J       Date:  2016-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.